New real-time, self-adjusting deep brain stimulation system transforms Parkinson’s care with personalized neuromodulation...
With plans to commercialize its pancreatic cancer test in the U.S. by late 2025, Immunovia seeks financial leadership with diagnostics expertise and global capital market experience....
Following constructive discussions with the FDA, Co-Dx shifts focus to an improved test submission, incorporating platform advancements and optimizing long-term performance....
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe. ...
With CE Mark certification, the AI-powered ECGenius System is now approved for commercialization in the European Economic Area, enhancing real-time electrogram recording and clinical decision-making for healthcare providers....
Leveraging machine learning, the Association Outlier Pattern (AOP) model provides real-time decision support and retrospective analysis, addressing surgical errors and strengthening healthcare reporting systems....
Designed for emergency settings, the new tray features the Ultraplex® 360 Needle with advanced echogenic technology, enabling precise regional anesthesia as a safer alternative to opioids. ...
Breakthrough Neurodiagnostic Device Aims to Transform Early Detection and Treatment of Neurological Disorders Across Europe...
The enhanced system now supports multiple languages, improving accessibility for global drug screening operations....
New joint research initiative combines UCSF’s clinical and research expertise with GE HealthCare’s engineering innovation to improve diagnosis, enhance access to precision treatments, and drive breakthroughs in brain health, oncology, and imaging technology....
